Overview

Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the bioavailability and safety of AGSAV301 tablet in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Ahn-Gook Pharmaceuticals Co.,Ltd
Collaborator:
Asan Medical Center
Treatments:
Amlodipine, Valsartan Drug Combination